Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar.
Fracasso PM, Blum KA, Ma MK, Tan BR, Wright LP, Goodner SA, Fears CL, Hou W, Arquette MA, Picus J, Denes A, Mortimer JE, Ratner L, Ivy SP, McLeod HL.
Fracasso PM, et al. Among authors: tan br.
Br J Cancer. 2005 Jul 11;93(1):46-53. doi: 10.1038/sj.bjc.6602653.
Br J Cancer. 2005.
PMID: 15942626
Free PMC article.
Clinical Trial.